Zenas BioPharma, Inc. (ZBIO) stock
ZBIONasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 1/30
$26.42−1.33 (-4.79%)
Close on Nov 18, 2026Market cap $1.72BP/E –Yield –
Zenas BioPharma total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Zenas BioPharma's total debt was $223.24M at Sep 30, 2026. For fiscal 2025 it was $78.64M.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $78.64M | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $223.24M | +205.9% |
| Q2 FY2026 | Jun 30, 2026 | $222.96M | – |
| Q1 FY2026 | Mar 31, 2026 | $193.63M | – |
| Q4 FY2025 | Dec 31, 2025 | $78.64M | – |
| Q3 FY2025 | Sep 30, 2025 | $72.99M | – |
See a number that looks wrong?